Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1933 1
1934 1
1938 1
1946 2
1948 2
1951 2
1953 1
1955 1
1956 3
1958 2
1959 1
1961 1
1962 2
1963 3
1964 1
1965 10
1966 2
1967 6
1968 12
1969 8
1970 4
1971 2
1972 3
1973 3
1974 3
1975 3
1976 1
1977 3
1978 2
1979 1
1982 3
1983 8
1984 6
1985 11
1986 15
1987 8
1988 9
1989 11
1990 6
1991 12
1992 16
1993 21
1994 19
1995 17
1996 20
1997 13
1998 15
1999 21
2000 18
2001 26
2002 20
2003 22
2004 27
2005 36
2006 38
2007 35
2008 38
2009 59
2010 48
2011 57
2012 56
2013 55
2014 94
2015 80
2016 81
2017 81
2018 87
2019 84
2020 96
2021 117
2022 92
2023 55

Text availability

Article attribute

Article type

Publication date

Search Results

1,553 results

Results by year

Filters applied: . Clear all
Page 1
Skin Cancer and Immunosuppression.
Collins L, Quinn A, Stasko T. Collins L, et al. Dermatol Clin. 2019 Jan;37(1):83-94. doi: 10.1016/j.det.2018.07.009. Epub 2018 Nov 1. Dermatol Clin. 2019. PMID: 30466691 Review.
Caregiver Care.
Swartz K, Collins LG. Swartz K, et al. Among authors: collins lg. Am Fam Physician. 2019 Jun 1;99(11):699-706. Am Fam Physician. 2019. PMID: 31150177 Free article.
Beyond mandates.
Collins LR. Collins LR. F S Rep. 2022 Nov 12;3(4):296-297. doi: 10.1016/j.xfre.2022.11.003. eCollection 2022 Dec. F S Rep. 2022. PMID: 36568930 Free PMC article. No abstract available.
Cutaneous adverse effects of the immune checkpoint inhibitors.
Collins LK, Chapman MS, Carter JB, Samie FH. Collins LK, et al. Curr Probl Cancer. 2017 Mar-Apr;41(2):125-128. doi: 10.1016/j.currproblcancer.2016.12.001. Epub 2016 Dec 14. Curr Probl Cancer. 2017. PMID: 28190531 Review.
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial.
Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Goodall HM, Ranade K, Holland C, Abdullah SE, Sacco JJ, Sato T. Carvajal RD, et al. Among authors: collins l. Nat Med. 2022 Nov;28(11):2364-2373. doi: 10.1038/s41591-022-02015-7. Epub 2022 Oct 13. Nat Med. 2022. PMID: 36229663 Free PMC article. Clinical Trial.
Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer.
Parsons HA, Rhoades J, Reed SC, Gydush G, Ram P, Exman P, Xiong K, Lo CC, Li T, Fleharty M, Kirkner GJ, Rotem D, Cohen O, Yu F, Fitarelli-Kiehl M, Leong KW, Hughes ME, Rosenberg SM, Collins LC, Miller KD, Blumenstiel B, Trippa L, Cibulskis C, Neuberg DS, DeFelice M, Freeman SS, Lennon NJ, Wagle N, Ha G, Stover DG, Choudhury AD, Getz G, Winer EP, Meyerson M, Lin NU, Krop I, Love JC, Makrigiorgos GM, Partridge AH, Mayer EL, Golub TR, Adalsteinsson VA. Parsons HA, et al. Among authors: collins lc. Clin Cancer Res. 2020 Jun 1;26(11):2556-2564. doi: 10.1158/1078-0432.CCR-19-3005. Epub 2020 Mar 13. Clin Cancer Res. 2020. PMID: 32170028 Free PMC article.
Molecular analysis of TCGA breast cancer histologic types.
Thennavan A, Beca F, Xia Y, Recio SG, Allison K, Collins LC, Tse GM, Chen YY, Schnitt SJ, Hoadley KA, Beck A, Perou CM. Thennavan A, et al. Among authors: collins lc. Cell Genom. 2021 Dec 8;1(3):100067. doi: 10.1016/j.xgen.2021.100067. Cell Genom. 2021. PMID: 35465400 Free PMC article.
1,553 results